Advanced Search

Dermatologic Pathology Evaluations

To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.

Sign in | Free Trial | Subscribe | Recommend to Library

New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.

SECTION HEADS

  • Photo of Lorenzo Cerroni

    Lorenzo Cerroni

    Department of Dermatology, Medical University of Graz, Graz, Austria

  • Photo of Philip LeBoit

    Philip LeBoit

    Department of Pathology, University of California (UCSF), San Francisco, CA, USA

Section Topics

  • » Classical morphology
  • » Immunohistology
  • » Molecular dermatopathology
  • » Neoplastic dermatopathology
  • » New techniques
  • » Non-neoplastic dermatopathology
  • » Teledermatopathology – telecommunication

TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]

8
Mast Cells Contribute to Scar Formation during Fetal Wound Healing.

Wulff BC, Parent AE, Meleski MA, Dipietro LA, Schrementi ME, Wilgus TA. J Invest Dermatol. 2012 Feb; 132(2):458-65

1 Evaluation, most recent by

Anthony Benedetto and Edward Monk, Dermatologic SurgiCenter, USA. F1000 Dermatology

INDIVIDUALS

Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or an individual subscription.

Get a FREE Trial Subscribe for $9.95 per month

Already have a subscription? Sign in for instant access. If you are signed in but are not able to view content, your access has expired. Please take out a subscription or recommend F1000 to your librarian.

RECOMMENDATIONS

Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.

Recommend to your Librarian

LIBRARIANS & INFORMATION MANAGERS

Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.

Request an Institutional Trial

FREE ACCESS

Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.